Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition

Journal of Ethnopharmacology

Volumn 116, Issue 2, 2008, Pages 363-369

  Shen, Hua Hao ^a   Wang, Kai ^a   Li, Wen ^a   Ying, Ying Hua ^a   Gao, Gui Xin ^a   Li, Xiao Bo ^a   Huang, Hua Qiong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Asthma; Astragalus Membranaceus; IFN ; IL 5

Indexed keywords

ASTRAGALUS MEMBRANACEUS EXTRACT; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 13; INTERLEUKIN 5; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; ASTRAGALUS MEMBRANACEUS; BODY PLETHYSMOGRAPHY; BRONCHUS HYPERREACTIVITY; CHINESE MEDICINE; CONTROLLED STUDY; HERB; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; MUCUS SECRETION; NONHUMAN; TH2 CELL;

ANIMALS; ASTRAGALUS PLANT; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; HYPERSENSITIVITY; MALE; MICE; MICE, INBRED C57BL; TH2 CELLS;

ASTRAGALUS MEMBRANACEUS; MUS;

EID: 39149143317     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.12.002     Document Type: Article

References (30)

1. Adamko D., et al. The eosinophil as a therapeutictarget in asthma: beginning of the end, or end of the beginning?. Current Opinion in Pharmacology 3 (2003) 227-232
2. Bedir E., et al. Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species. Biological and Pharmaceutical Bulletin 23 (2000) 834-837
3. Block K.I., et al. Immune system effects of echinacea, ginseng, and astragalus: a review. Integrative Cancer Therapies 2 (2003) 247-267
4. Cohn L., et al. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. The Journal of Experimental Medicine 186 (1997) 1737-1747
5. Cui R., et al. Suppressive effect of Astragalus Membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemotherapy and Pharmacology 51 (2003) 75-80
6. Fang S.P., et al. Immunomodulatory effects of gyokuheifusan on INF-gamma/IL-4 (Th1/Th2) balance in ovalbumin (Ova)-induced asthma model mice. Biological and Pharmaceutical Bulletin 28 (2005) 829-833
7. Foster P.S., et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. Journal of Experimental Medicine 183 (1996) 195-201
8. Gavett S.H., et al. Depletion of murine CD4 + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. American Journal of Respiratory Cell and Molecular Biology 10 (1994) 587-593
9. Grunig G., et al. Requirement for IL-4 in experimental asthma. Science 282 (1998) 2261-2263
10. Ishimitsu R., et al. Dichotomous effect of a traditional Japanese medicine, bu-zhong-yi-qi-tang on allergic asthma in mice. International Journal of Immunopharmacology 1 (2001) 857-865
11. Jenmalm M.C., et al. Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses. Pediatric Allergy and Immunology 10 (1999) 168-177
12. Kang H., et al. Immunomodulatory effect of Astragali Radix extract on murine Th1/Th2 cell lineage development. Biological and Pharmaceutical Bulletin 27 (2004) 1946-1950
13. Kelly-Welch A.E., et al. Complex role of the IL-4 receptor alpha in a murine model of airwayinflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation. Journal of Immunology 172 (2004) 4545-4555
14. Kon O.M., et al. T cells and chronic asthma. International Archives of Allergy and Immunology 118 (1999) 133-135
15. Kurashige S., et al. Effects of astragali radix extract on carcinogenesis, cytokine production, and cytotoxicity in mice treated with a carcinogen. N-butyl-N′-butanolnitrosoamine. Cancer Investigation 17 (1999) 30-35
16. Larche M., et al. The role of T lymphocytes in the pathogenesis of asthma. Journal of Allergy and Clinical Immunology 111 (2003) 450-463
17. Lau B.H., et al. Chinese medicinal herbs inhibit growth of murine renal cell carcinoma. Cancer Biotherapy 9 (1994) 153-161
18. Masoli M., et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 (2004) 469-478
19. Mckenna D.J., et al. Astragalus. Alternative Therapies in Health and Medicine 8 (2002) 34-40
20. Ray A., et al. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. Journal of Clinical Investigation 104 (1999) 985-993
21. Sally E.W., et al. Update in asthma. American Journal of Respiratory and Critical Care Medicine 173 (2005) 698-706
22. Steinke J.W. Anti-interleukin-4 therapy. Immunology and Allergy Clinics of North America 24 (2004) 599-614
23. Suzuki T., et al. Suppressive effects of Hochu-ekki-to, a traditional Chinese medicine, on IgE production and histamine release in mice immunized with ovalbumin. Biological and Pharmaceutical Bulletin 22 (1999) 1180-1184
24. Wang, R.T., et al., 2002. Extracorporeal experimental study on immuno-modulatory activity of Astragalus Membranaceus extract. Zhongguo Zhong Xi Yi Jie He Za Zhi 22, 453-456.
25. Wei H., et al. Traditional Chinese medicine Astragalus reverses predominance of Th2 cytokines and their up-stream transcript factors in lung cancer patients. Oncology Reports 10 (2003) 1507-1512
26. Wills-Karp M., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
27. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annual Review of Immunology 17 (1999) 255-281
28. Yoshida Y., et al. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. International Journal of Immunopharmacology 19 (1997) 359-370
29. Yu F., et al. Traditional Chinese medicine and Kampo: a review from the distant past for the future. Journal of International Medical Research 34 (2006) 231-239
30. Zhu A., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalitites, and eotaxin production. Journal of Clinical Investigation 103 (1999) 779-788